Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement
GH replacement therapy leads to modulation of the inflammatory response in panhypopituitary patients with decrease of adhesion molecules E-selectin, P-selectin and ICAM-1as markers of the endothelial damage